Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, including the makers of Xarelto, possess a duty to make sure that their drugs are reasonably safe for use - and failure to complete so could be grounds for compensation. Our lawyers are operating hard to obtain those hurt by the drug the compensation they're entitled to.While bleeding is actually a typical complication linked with anticoagulants, it has been alleged that Xarelto is far more unsafe than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, inside the occasion of an emergency, individuals may be at danger for irreversible bleeding issues, including life-threatening internal and gastrointestinal hemorrhaging.If you or a loved one suffered a severe bleeding event right after taking Xarelto, you might have legal recourse. For much more information, make contact with us these days to have your case reviewed, free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in situations of death, funeral costs. In addition, they're searching for punitive damages, which are usually awarded to punish the defendant and deter other companies from acting similarly.Why Are Lawsuits Becoming Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, Full Record the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a secure anticoagulant option.Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.Visit this page for more data on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.